View all cases
UPC CFI 11/2025
Jan 20, 2025·EP2196231 · System for ambulatory drug infusion comprising a filling apparatus for flexible containers
Action number: ACT 831/2025
- Case details
- StatusCase ClosedActionGenericCategoryGeneric
- Parties
- Claimants
- Roche Diabetes Care GmbHOperating co.
Representatives- Christof Augenstein-Kather Augenstein
- Katharina Brandt-Kather Augenstein
- Robert Knaps-Kather Augenstein
- Thomas Kronberger-Grünecker Patent- und Rechtsanwälte PartGmbH
Respondents- Tandem Diabetes Care, Inc.Operating co.
- Tandem Diabetes Care Europe B.V.Operating co.
Representatives- Christian Dekoninck-Taylor Wessing
- Charlotte Garnitsch-Taylor Wessing
- Wim Maas-Taylor Wessing
- Pauline Springorum-Taylor Wessing
- Alexander Rubusch-Taylor Wessing
- George Seezink-AOMB
- Division
- Paris CD
- Technology
- InstrumentsMedical technology
- Language
- English
- First decided
- Apr 29, 2025
How this compares
How long the court takes to reach a first decision.
| Median days to first decision | |
|---|---|
| All UPC | 124 |
| Paris CD | Locked |
| Judge Paolo Catallozzi | Locked |
| Judge Tatyana Zhilova | Locked |
| Judge Giorgio Checcacci | Locked |
At the UPC: Roche Group (29 cases)·Tandem Diabetes Care Group (18 cases)
Start 14-day free trialAlready a user? Sign in
Related cases
All proceedings on this patentThis dispute contains 9 other proceedings
UPC CoA 120/2025·UPC CFI 88/2024·UPC CFI 454/2023·UPC CFI 455/2023·UPC APP 3514/2024 and 4 more
1 other defendants litigating the same or a related patent
Decisions
- 2025-04-29Application For CostsPublic
Summary: The Central Division Paris issued a costs order in connection with the revocation action UPC_CFI_454/2023, requiring Tandem Diabetes to pay Roche Diabetes Care's representation and litigation costs. The Court rejected Tandem Diabetes's request to stay the costs proceedings pending the appeal against the decision on the merits.
Show the legal issues (5)
- Costs decision
- Stay of costs proceedings
- Pending appeal against merits decision
- Reimbursable representation costs ceiling
- Art. 69 UPCA
Documents
| Document title | Date | Public |
|---|---|---|
| Final order 831-25 anonymized | 2025-04-30 | Not public |
| Final order - app for a cost decision 831-25 | 2025-04-30 | Not public |
| Headnote-and-Keywords | 2025-04-29 | Not public |
| Application-For-Costs-Decision-Outcome | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| cost decision | 2025-04-29 | Public |
| cost decision | 2025-04-29 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |
| Comments Cost Application | 2025-03-21 | Not public |
| Final order anonymized 06.03.2025 | 2025-03-10 | Not public |
| preliminary order | 2025-03-06 | Not public |
| rule 262A | 2025-03-06 | Public |
| rule 262A | 2025-03-06 | Not public |
| Exhibit KAP KFA 17 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 06 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 13 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 18 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 14 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 09 - Redacted | 2025-03-04 | Not public |
| 2025-01-20 Application for a cost decision Roche_redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 08 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 11 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 04 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 19 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 03 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 01 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 07 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 10 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 15 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 12 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 02 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 05 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 16 - Redacted | 2025-03-04 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 06 -EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 17 -EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| 2025-03-04 Submission Roche | 2025-03-04 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 14 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL_UNREDACTED.pdf | 2025-03-04 | Not public |
| Preliminary order anonymized - 3143/2025 | 2025-02-26 | Not public |
| Outcome of the Order | 2025-02-25 | Not public |
| rule 262 (A) | 2025-02-25 | Not public |
| rule 262 (A) | 2025-02-25 | Public |
| Response to Order of the Court - Comments to Application pursuant to Rule 262A | 2025-02-13 | Not public |
| Response to Order of the Court - Comments to Application pursuant to Rule 262A | 2025-02-13 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL | 2025-02-03 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| 2025-02-03 Brief Roche regarding submission confidential documents_signed | 2025-02-03 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-02-03 | Not public |
| Preliminary order anonymized 29.01.2025 | 2025-01-29 | Not public |
| rule 262 (A) | 2025-01-29 | Public |
| rule 262 (A) | 2025-01-29 | Not public |
| Panel-Appointment | 2025-01-20 | Not public |
| Receipt | 2025-01-20 | Not public |
| Receipt | 2025-01-20 | Not public |
| 2025-01-20 Application for confidentiality R 262A_signed | 2025-01-20 | Not public |
| 2025-01-20 Application for confidentiality R 262_2_signed | 2025-01-20 | Not public |
| Acknowledgement-of-lodging | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 20 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 21 - EN.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 25 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 24 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 23 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 05 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 22 - DE.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 02 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| 2025-01-20 Application for a cost decision Roche_STRICTLY CONFIDENTIAL_signed | 2025-01-20 | Not public |
| Exhibit KAP KFA 09 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 18 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 17 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 11 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 01 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 15 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 19 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 10 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 03 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 16 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 13 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 08 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 12 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 14 - EN _STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 04 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 06 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |
| Exhibit KAP KFA 07 - EN_STRICTLY CONFIDENTIAL.pdf | 2025-01-20 | Not public |